NASDAQ:STAA

STAAR Surgical (STAA) Stock Forecast, Price & News

$39.41

+0.02 (+0.05%)

(As of 09/22/2023 ET)

Compare

Today's Range: $39.16
▼
$40.66
50-Day Range: $39.39
▼
$57.72
52-Week Range: $39.12
▼
$81.81

Volume: 372,663 shs
Average Volume: 771,647 shs
Market Capitalization: $1.91 billion

P/E Ratio: 78.82
Dividend Yield: N/A
Price Target: $58.50

STAAR Surgical MarketRank™ Forecast

Analyst Rating: Hold
2.42 Rating Score
Upside/Downside: 48.4% Upside
$58.50 Price Target
Short Interest: Bearish
13.73% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.73
Upright™ Environmental Score
News Sentiment: 0.53
Based on 12 Articles This Week
Insider Trading: Acquiring Shares
$9.87 M Bought Last Quarter
Proj. Earnings Growth: 48.08%
From $0.52 to $0.77 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.04 out of 5 stars

Medical Sector

29th out of 962 stocks

Ophthalmic Goods Industry

1st out of 7 stocks

4.2

Analyst's Opinion

Consensus Rating
STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on 5 buy ratings, 7 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $58.50, STAAR Surgical has a forecasted upside of 48.4% from its current price of $39.41.
Amount of Analyst Coverage
STAAR Surgical has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.0

Short Interest

Percentage of Shares Shorted
13.73% of the outstanding shares of STAAR Surgical have been sold short.
Short Interest Ratio / Days to Cover
STAAR Surgical has a short interest ratio ("days to cover") of 7.5.
Change versus previous month
Short interest in STAAR Surgical has recently increased by 9.90%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
STAAR Surgical does not currently pay a dividend.
Dividend Growth
STAAR Surgical does not have a long track record of dividend growth.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
STAAR Surgical has received a 58.64% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Intraocular lenses" product. See details.
Environmental Sustainability
The Environmental Impact score for STAAR Surgical is -0.73.

3.1

News and Social Media Coverage

News Sentiment
STAAR Surgical has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 12 news articles for STAAR Surgical this week, compared to 5 articles on an average week.
Search Interest
5 people have searched for STAA on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
MarketBeat Follows
5 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, STAAR Surgical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,869,857.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 1.10% of the stock of STAAR Surgical is held by insiders.
Percentage Held by Institutions
96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for STAAR Surgical are expected to grow by 48.08% in the coming year, from $0.52 to $0.77 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of STAAR Surgical is 78.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.34.
Price to Earnings Ratio vs. Sector
The P/E ratio of STAAR Surgical is 78.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 114.94.
Price to Book Value per Share Ratio
STAAR Surgical has a P/B Ratio of 5.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAA Price History

30 days | 90 days | 365 days | Advanced Chart

STAA Stock News Headlines

September 24, 2023 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Price Target Cut to $40.00

September 23, 2023 | americanbankingnews.com

Broadwood Partners, L.P. Buys 154,814 Shares of STAAR Surgical (NASDAQ:STAA) Stock

September 24, 2023 | Altimetry (Ad)

DOD Consultant's big 2024 prediction looks to be coming true

Earlier this year, a Department of Defense (DOD) consultant went public with a big prediction…About how a surprising 2024 event would dramatically affect you and your money. The most recent figures (published June 9th 2023) indicate he’s very likely to be right. Get the facts—learn how to prepare. Full analysis available free of charge here…

September 22, 2023 | markets.businessinsider.com

Over $11M Bet On STAAR Surgical? Check Out These 3 Stocks Insiders Are Buying

September 19, 2023 | finance.yahoo.com

Is STAAR Surgical Company (NASDAQ:STAA) Trading At A 32% Discount?

September 19, 2023 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Receives Average Rating of "Hold" from Analysts

September 17, 2023 | americanbankingnews.com

Needham & Company LLC Cuts STAAR Surgical (NASDAQ:STAA) Price Target to $52.00

September 17, 2023 | americanbankingnews.com

Piper Sandler Trims STAAR Surgical (NASDAQ:STAA) Target Price to $45.00

September 24, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.

September 17, 2023 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Rating Lowered to Hold at Benchmark

September 17, 2023 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Downgraded by Benchmark

September 16, 2023 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Downgraded by StockNews.com

September 16, 2023 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Shares Gap Down After Analyst Downgrade

September 15, 2023 | seekingalpha.com

Staar Surgical sees FY26 sales $500M-$550M, operating margin of 12%-16%

September 15, 2023 | msn.com

Mizuho Reiterates Staar Surgical (STAA) Buy Recommendation

September 15, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Arcturus Therapeutics (ARCT) and Acrivon Therapeutics, Inc. (ACRV)

September 15, 2023 | americanbankingnews.com

STAAR Surgical's (STAA) "Buy" Rating Reiterated at Mizuho

September 15, 2023 | americanbankingnews.com

STAAR Surgical's (STAA) "Hold" Rating Reaffirmed at Stifel Nicolaus

September 14, 2023 | markets.businessinsider.com

BTIG Sticks to Their Hold Rating for Staar Surgical (STAA)

September 14, 2023 | finance.yahoo.com

Is Staar Surgical Co (STAA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap

September 14, 2023 | finance.yahoo.com

STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023

September 13, 2023 | msn.com

Stifel Reiterates Staar Surgical (STAA) Hold Recommendation

September 13, 2023 | markets.businessinsider.com

8 Analysts Have This to Say About Staar Surgical

September 11, 2023 | markets.businessinsider.com

BTIG Reaffirms Their Hold Rating on Staar Surgical (STAA)

September 8, 2023 | finance.yahoo.com

Staar Surgical Co (STAA): A Potential Value Trap?

September 8, 2023 | markets.businessinsider.com

Around $8M Bet On STAAR Surgical? Check Out These 4 Stocks Insiders Are Buying

September 7, 2023 | finance.yahoo.com

STAAR Surgical to Host "Vision 2026" Investor Day on September 14, 2023

See More Headlines

Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Company Calendar

Last Earnings: 8/02/2023
Today: 9/24/2023
Next Earnings (Estimated): 11/01/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Ophthalmic goods
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NASDAQ:STAA
CUSIP: 85231230
CIK: 718937
Web: www.staar.com
Phone: (626) 303-7902
Fax: 626-303-2962
Employees: 882
Year Founded: 1982

Price Target and Rating

Average Stock Price Forecast: $58.50
High Stock Price Forecast: $88.00
Low Stock Price Forecast: $40.00
Forecasted Upside/Downside: +48.4%
Consensus Rating: Hold
Rating Score (0-4): 2.42
Research Coverage: 12 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.50
Trailing P/E Ratio: 78.82
Forward P/E Ratio: 75.79
P/E Growth: N/A
Net Income: $38.76 million
Net Margins: 8.14%
Pretax Margin: 10.38%
Return on Equity: 8.37%
Return on Assets: 6.74%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.05
Quick Ratio: 5.58

Sales & Book Value

Annual Sales: $284.39 million
Price / Sales: 6.72
Cash Flow: $0.89 per share
Price / Cash Flow: 44.19
Book Value: $6.89 per share
Price / Book: 5.72

Miscellaneous

Outstanding Shares: 48,500,000
Free Float: 47,967,000
Market Cap: $1.91 billion
Optionable: Optionable
Beta: 1.09

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Thomas G. Frinzi (Age 67)
Pres, CEO & Chairman
Comp: $94.48k

Mr. Patrick F. Williams (Age 50)
Chief Financial Officer
Comp: $959.99k

Dr. Keith Holliday Ph.D. (Age 60)
Chief Technology Officer
Comp: $829.09k

Mr. James Francese (Age 59)
Sr. VP of Commercial Operations - North America & APAC
Comp: $755.65k

Ms. Caren L. Mason (Age 69)
Advisor
Comp: $1.95M

Dr. Scott D. Barnes M.D. (Age 61)
Chief Medical Officer
Comp: $828.3k

Mr. Warren Foust (Age 47)
Chief Operating Officer

Mr. Brian Moore
VP of Investor, Media Relations & Corp. Devel.

Mr. Samuel J. Gesten (Age 61)
Chief Legal Officer & Corp. Sec.

Dr. Magda Michna Ph.D.
Chief Clinical, Regulatory & Medical Affairs Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

STAA Stock - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?: 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 7 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" STAA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View STAA analyst ratings or view top-rated stocks.
What is STAAR Surgical's stock price forecast for 2023?: 12 equities research analysts have issued 12 month price objectives for STAAR Surgical's shares. Their STAA share price forecasts range from $40.00 to $88.00. On average, they expect the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 48.4% from the stock's current price.
View analysts price targets for STAA or view top-rated stocks among Wall Street analysts.
How have STAA shares performed in 2023?: STAAR Surgical's stock was trading at $48.54 at the beginning of the year. Since then, STAA stock has decreased by 18.8% and is now trading at $39.41.
View the best growth stocks for 2023 here.
When is STAAR Surgical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our STAA earnings forecast.
How were STAAR Surgical's earnings last quarter?: STAAR Surgical (NASDAQ:STAA) issued its earnings results on Wednesday, August, 2nd. The medical instruments supplier reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.04. The medical instruments supplier had revenue of $92.31 million for the quarter, compared to the consensus estimate of $93.04 million. STAAR Surgical had a trailing twelve-month return on equity of 8.37% and a net margin of 8.14%.
What ETFs hold STAAR Surgical's stock?: ETFs with the largest weight of STAAR Surgical (NASDAQ:STAA) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC) and Pacer US Export Leaders ETF (PEXL).iShares U.S. Medical Devices ETF (IHI).
What guidance has STAAR Surgical issued on next quarter's earnings?: STAAR Surgical issued an update on its FY 2026 earnings guidance on Thursday, September, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $500.00 million-$550.00 million.
What is Caren Mason's approval rating as STAAR Surgical's CEO?: 6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).
What is STAAR Surgical's stock symbol?: STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."
Who are STAAR Surgical's major shareholders?: STAAR Surgical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.07%), Baillie Gifford & Co. (10.57%), State Street Corp (3.62%), Jackson Square Partners LLC (2.83%), Geode Capital Management LLC (2.06%) and Geneva Capital Management LLC (1.97%). Insiders that own company stock include Aimee S Weisner, Broadwood Partners, LP, Caren L Mason, Elizabeth Yeu Lin, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends.
How do I buy shares of STAAR Surgical?: Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is STAAR Surgical's stock price today?: One share of STAA stock can currently be purchased for approximately $39.41.
How much money does STAAR Surgical make?: STAAR Surgical (NASDAQ:STAA) has a market capitalization of $1.91 billion and generates $284.39 million in revenue each year. The medical instruments supplier earns $38.76 million in net income (profit) each year or $0.50 on an earnings per share basis.
How many employees does STAAR Surgical have?: The company employs 882 workers across the globe.
Does STAAR Surgical have any subsidiaries?: The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
How can I contact STAAR Surgical?: STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.

This page (NASDAQ:STAA) was last updated on 9/24/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

STAAR Surgical (STAA) Stock Forecast, Price & News

STAAR Surgical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About STAAR Surgical (NASDAQ:STAA) Stock

STAA Price History

STAA Stock News Headlines

STAA Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

STAA Stock - Frequently Asked Questions

Overall MarketRank^™